Status:
COMPLETED
Using Video Images to Improve Advance Care Planning in Patients With Cancer
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Advanced Cancer
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their in...
Detailed Description
The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their in...
Eligibility Criteria
Inclusion
- Terminal, progressive cancer with poor prognosis whose treatment intent is palliative, based on the following definition:
- All patients with brain cancer, liver cancer, inoperable non-small cell lung carcinoma, pancreatic cancer, or gallbladder cancer; OR
- Patients with the following cancers: metastatic colon cancer or stage III or IV non-small cell lung cancer; OR
- Patients with the following cancers, if first-line therapy has failed and limited response is expected to second-line therapy: breast cancer, colorectal cancer, head and neck cancer, stomach cancer, esophageal cancer, melanoma, leukemia, ovarian cancer, prostate cancer, renal cancer, sarcoma, lung cancer, myeloma, or lymphoma.
- The terms terminal, progressive, poor prognosis, palliative intent and limited response will be judged by the patient's oncologist (and not by the RSA or consenting professional).
- Return patient visit (defined as a patient known to the oncologist from previous assessments and treatments, where the working and personal relationship has been established and not a new patient to the clinic).
- English speaking. Only English-speaking patients will be included in our present study since English is the validated language of our study tools.
- Given the sensitive nature of the study, clinicians will decide whether the patient is a potentially appropriate subject based on their knowledge of the patient.
- Able to provide informed consent.
- Age greater than or equal to 21.
Exclusion
- MMSE \< 25.
- Psychological state not appropriate for end-of-life discussion as determined by the treating clinician.
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00970125
Start Date
August 1 2009
End Date
June 1 2011
Last Update
May 1 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering
New York, New York, United States, 10065